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get. This involves both oligomerization of the capsid (C)
protein and packaging of the viral RNA. The RNA binding
properties of the C protein is poorly understood. This study
aims to characterize the C and RNA interaction. Method:
Co-localization study was performed by transfecting in vitro
transcribed WN virus RNA and C protein clones into BHK cells
and visualized under ﬂuorescence microscopy. RNA bind-
ing properties of C protein were further investigated with
a Northwestern Blot assay and RNA pull-down assay. Syn-
thesized C protein peptides were used to map out the RNA
binding regions on C protein. In addition, C protein immuno-
puriﬁed from BHK cells were used to investigate the effect of
phosphorylation of C protein on its RNA binding properties.
Results: RNA and C protein have failed to show co-
localization in BHK cells by immuno-ﬂuorescence but
interactions were observed at the molecular level. It showed
that the ﬁrst 465 and last 693 nucleotides of the WN virus
RNA had speciﬁc afﬁnity for the full length C protein. In addi-
tion, the amino- and carboxy-terminal of the C protein were
shown to bind to the virus RNA. It was also found that the C
protein had afﬁnity for viral anti-sense RNA. Phosphorylated
peptides of C protein and C protein expressed in BHK cells
show attenuated binding to viral RNA.
Conclusion: C protein interaction with anti-sense indi-
cates that its interaction with viral sense RNA may not
be speciﬁc. Phosphorylation of C protein could play a role
in regulating C and RNA interaction and allow time for
viral assembly. Understanding the interaction of C protein
with viral RNA and role of phosphorylation in nucleocapsid
assembly could help develop anti-viral strategies aimed at
disrupting viral assembly.
doi:10.1016/j.ijid.2008.05.787
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Background: West Nile virus (WNV), a member of Fla-
viviridae family is a viral agent that transmitted by numerous
species of mosquitoes and birds. It is known to cause fever,
paralysis and encephalitic maladies in infected humans and
animals. The WNV particle is made up of premembrane
(prM), envelope (E) and capsid proteins. The prM protein
mediates the folding of the viral envelope (E) protein and
protects the E protein against premature acidiﬁcation during
virus maturation. To date, critical residues responsible for
prM function in viral assembly are yet to be deﬁned. There is
no antiviral drug or vaccine available for treatment of WNV
infection in humans. Understanding the molecular mecha-
nism of virus assembly will identify new vulnerable sites of
virus replication and expedite the discovery and develop-
ment of new therapeutics to treat WNV-induced diseases.
Methods: In this study, multiple sequence analysis identi-
ﬁed a number of highly conserved residues in the prM protein
among the ﬂaviviruses. To investigate the signiﬁcance of
these residues, multi-site and single point mutagenesis
work in WNV infectious clone were carried out to generate
mutant WNV viruses. The effects of the amino acid replace-
ments on virus infectivity, secretion, growth kinetics and
assembly were carried out using plaque assay, biochemical
techniques, immunoﬂourescence and transmission electron
microscopy.
Results & conclusion: Our study discovered that Tyrosine
78 is absolutely required for virus infectivity and replication
in BHK and C6/36 cells. This is supported by positive and
negative complementation assays performed by expressing
wildtype and Y78A prM protein in trans. The Tyrosine 78
residue is also highly conserved in Dengue and Japanese
Encephalitis, raising the possibility that this amino acid is
equally important. Future experiments will explore vari-
ous molecular strategies targeting Tyrosine 78 residue. This
will potentially unravel a broad-spectrum assembly inhibitor
against the ﬂaviviruses.
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Background: In an earlier study, NS1 was also shown
to be able to interact with STAT3 , an acute-phase pro-
tein and NS1 over-expression in dendritic cells results in
increased production of pro-inﬂammatory cytokines. These
results points towards a role played by NS1 in the patho-
genesis of dengue virus infection. Hence, this study aims to
further our current understanding of this role played by NS1,
in particular, its effects on STAT3 signaling.
Methods: First, the yeast-two-hybrid (Y2H) system was
used to map the interaction domains between STAT3 
and NS1. This technique was also used to probe for the
ability of NS1 to interact with the -isoform of STAT3. Co-
immunoprecipitation and immunoﬂuorescent assays were
also used to investigate this interaction.
Results: From the Y2H screen, the interaction domain
was mapped to the coiled-coiled domain of STAT3. Interest-
ingly, however, STAT3 , fail to interact with NS1 in the Y2H
system. Further experiments in the mammalian system using
co-immunoprecipitation and immunoﬂuorescent assays also
support this ﬁnding that STAT3 was incapable of interacting
with NS1.
Conclusion: Since STAT3  activation is known to nega-
tively regulate STAT1-dependent type I interferon antiviral
response and STAT3  is known to be the dominant nega-
tive form of STAT3 , this unique interaction of NS1 with
STAT3  only, could potentially reduce the inhibitory effect
of STAT3  on STAT3 , thereby increasing STAT3  activation,
consequently down-regulating the type I interferon antiviral
response. This modulation of STAT3 signaling could be one of
the strategies employed by dengue virus to evade the host
anti-viral immune response.
doi:10.1016/j.ijid.2008.05.789
